PNC Financial Services Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-389
Closed -$2K 4700
2016
Q2
$2K Sell
389
-15
-4% -$77 ﹤0.01% 4320
2016
Q1
$2K Buy
404
+14
+4% +$56 ﹤0.01% 4324
2015
Q4
$2K Hold
390
﹤0.01% 4287
2015
Q3
$2K Buy
390
+13
+3% +$159 ﹤0.01% 4416
2015
Q2
$6K Buy
377
+183
+94% +$2.22K ﹤0.01% 4052
2015
Q1
$2K Hold
194
﹤0.01% 4420
2014
Q4
$2K Hold
194
﹤0.01% 3933
2014
Q3
$2K Hold
194
﹤0.01% 3783
2014
Q2
$2K Hold
194
﹤0.01% 3646
2014
Q1
$2K Buy
+194
New +$2.8K ﹤0.01% 3637

Other funds holding RPTP

PNC Financial Services Group's RPTP Position: Q3 2016 in Review

PNC Financial Services Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 389 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in RPTP in Q1 2014 and held it in 10 quarters. The position peaked at $6K in Q2 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • PNC Financial Services Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 389 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $2K.
  • PNC Financial Services Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2014 and held it in 10 quarters.
  • PNC Financial Services Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $6K in Q2 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.